Maybank Shares Rise 1.5%, Analysts Maintain 'Buy' Rating

February 25, 2026
Company News
Bursa Malaysia

Malayan Banking Bhd (Maybank) shares climbed 1.5% to RM9.25, supported by strong Q4 earnings expectations and a stable dividend policy. Analysts are generally optimistic about its future performance, maintaining 'Buy' ratings.

Malayan Banking Bhd (Maybank) shares showed robust performance today, rising 1.5% to RM9.25, becoming one of the main drivers for the KLCI. The market generally anticipates strong performance from the bank's upcoming Q4 FY2025 results, primarily due to growth in net interest income and improved asset quality. Analysts highlighted that Maybank's consistent dividend payout record also attracts yield-seeking investors. CGS-CIMB Research maintained its 'Buy' rating on Maybank with a target price of RM9.80, citing its strong franchise and exposure to regional economic recovery. Other blue-chip stocks like Tenaga Nasional Bhd saw a slight dip of 0.3%, while Top Glove gained 0.5%.
Share:
Sunlight Capital
SUNLIGHTCapital Group

SunLight General Capital is a comprehensive investment company headquartered in New York, USA, founded in 2009. Core business includes solar facility development, financing, acquisition and operations, as well as AI-driven Malaysian stock market research and institutional education.

AI-Powered Investment Platform
New York Headquarters
1 World Trade Center, Suite 8500, New York, NY 10007, USA
Singapore Office
80 Raffles Place, No. 18-01 UOB Plaza 1 Singapore 048624
+1 (212) 286-1801
SunlightCapital8.com

Business Areas

  • Solar Project Development
  • Asset Acquisition & Operations
  • AI Investment Program
  • Institutional Investment Education
550+
Solar Facilities
99.9%
AI Stability

© 2026 SunLight General Capital. All rights reserved.

The content of this website is for reference only and does not constitute investment advice. Investment involves risks, investors should make decisions carefully based on their own circumstances. Past performance of AI programs does not guarantee future results.